Gene · 360
NIH grants937
NIH grants whose papers are about the gene, through NIH's grant-paper links.
81 to 100 of 937
Download this page as JSON| Grant | Title | AQP3 papers | Newest fiscal year |
|---|---|---|---|
| P51OD011133 | The Southwest National Primate Research Center | 1 | 2025 |
| R01AI022553 | Molecular Analysis of Host Immune Response in Leprosy | 1 | 2025 |
| R01AI056273 | Functional Characterization of the Schistosome Tegument | 1 | 2025 |
| R01AI113142 | Designing induction therapies to target memory T cells in high risk recipients | 1 | 2025 |
| R01AI118891 | Viral modulation of epitranscriptomic mechanisms | 1 | 2025 |
| R01AI130379 | Role of the prostaglandin D2 receptor CRTH2 in helminth-induced type 2 inflammation in the intestine | 1 | 2025 |
| R01AI158719 | Evaluating the role of P53 pathways in malaria | 1 | 2025 |
| R01AI166313 | Dynamics of the cellular and molecular architecture of human pulmonary TB granulomas | 1 | 2025 |
| R01AI177257 | Perturbations of host cell signaling by a complex hepatotropic pathogen | 1 | 2025 |
| R01AR056439 | Circadian Clock Regulation in Skin | 1 | 2025 |
| R01CA102184 | Functional Analysis of p53 Polymorphic Variants | 1 | 2025 |
| R01CA251621 | MDC1: central regulator of estrogen receptor function and therapy response in lobular carcinoma | 1 | 2025 |
| R01CA252878 | CXCL5/CXCR2 axis as a therapeutic vulnerability of breast cancer metastasis to bone | 1 | 2025 |
| R01CA254970 | Novel small molecule USP7 Inhibitors for p53 activation and cancer therapy | 1 | 2025 |
| R01CA258589 | Small molecules to target the RNA methyltransferase complex METTL3/METTL14 | 1 | 2025 |
| R01CA260752 | Targeting the fibroblast-immune cell crosstalk to relieve immune suppression in the pancreatic cancer microenvironment | 1 | 2025 |
| R01CA268426 | Mechanisms of myeloid cell driven pancreatic plasticity and carcinogenesis | 1 | 2025 |
| R01CA271510 | Dissecting the role of Notch signaling in the pancreatic cancer microenvironment. | 1 | 2025 |
| R01CA272687 | Cell plasticity in the origin of gastric carcinogenesis | 1 | 2025 |
| R01DC004336 | Engineering the Vocal Fold Mucosa | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/360/grants?page=5